Checklist Of Books Educational Technology Publications: Fill & Download for Free

With full disclosure that I am completely biased, I'll throw into the ring my own book, The Startup Checklist: 25 Steps to a Scalable, High-Growth Business. It is narrowly focused on the high growth startup world, and deals with the entire process from idea modeling and the lean start model, through equity allocation, legal set up and administration, all the way to venture fundraising and your eventual exit.For a bit of validation, it is a New York Times best seller, has a five star rating on Amazon, a strong Kirkus review, and is given to the incoming portfolio companies at major accelerator programs like Founder Institute, DreamIt Ventures, Singularity University and CUNY as their roadmap.The book outlines the specific ins-and-outs of starting up a high-growth business in the 21st century, detailing solutions that can save you tens, or even hundreds, of thousands of dollars on the path of scaling your venture. To give you an idea of what I cover in the book, here’s the Table of Contents:PART ONE: PREPARE TO LAUNCH1. Translate Your Idea into a Compelling Business Model2. Craft a Business Plan to Serve as Your “Plan A” Roadmap3. Find and Know Your Competitors4. Draft your Founding Dream Team5. Allocate the Equity in Your Startup6. Build a Minimum Viable Product and Validate Your Plan with Customers7. Establish Your Brand with Online Public Profiles8. Network Effectively within the Entrepreneurial EcosystemPART TWO: LAUNCH AND BUILD YOUR COMPANY9. Incorporate as a Delaware “C” Corporation for Protection and Investment10. “Lawyer Up” the Right Way11. Recruit your Boards of Directors and Advisors12. Select an Accountant and an Accounting System13. Establish and Manage your Credit Profile14. Open Bank, Credit Card and Merchant Accounts15. Choose Your Key Technologies, Platforms and Vendors16. Measure Your Business with Data Analytics17. Round Out Your Team with Employees and Freelancers18. Establish a Stock Option Plan to Incentivize Your TeamPART THREE: RAISE FUNDS; COLLABORATE WITH INVESTORS; PLAN FOR YOUR EXIT19. Understand the Funding Process and What Investors Want to See20. Nurture Your Investor Pipeline21. Fundraise with Online Platforms22. Survive the Term Sheet Negotiation and Investor Due Diligence23. Get the Most from Your Investors, Now and in the Future24. Understand Your Company’s Valuation for Funding vs. Option Grants25. Keep Your Eye on the Exit and Reap the Benefits of Success————“Finally! The indispensable instruction book that takes you from your Big Idea to a Big Exit. In his inimitable wise and witty style, David takes founders through the nuts and bolts of how to start a company that can successfully make it all the way to the finish line. I’m giving copies to all of my entrepreneurs!”—Barbara Corcoran (Business Expert and Star of ABC’s Shark Tank)"This book is an absolute must for anybody looking to start a high-growth startup and get funding. David is an institution among high-tech angel investors, who brings his experience on both sides of it (as startup founder and angel investor) to play in this practical, realistic book."—Tim Berry (Author of Business Plan Pro)“I work with hundreds of first-time entrepreneurs and The Startup Checklist is the clearest, most useful resource I have seen for someone considering starting a scalable, high-growth business. Experience may be the best teacher, but right behind her is David S. Rose.”—Andrew Yang (Founder and CEO of Venture for America and author of Smart People Should Build Things)“Everyone knows that a great business starts with a great idea. But the journey from a great idea to a flourishing, profitable business is a lot longer and thornier than most people realize. I can’t imagine a more experienced, savvier, street-smart guide along the way than David S. Rose’s The Startup Checklist.”—Howard L. Morgan (Co-founder, First Round Capital)“The Startup Checklist should be required reading for every entrepreneur. It walks you step by step through the entire process of building a seriously big company, and will save you from making all-too-common mistakes that can easily kill an otherwise promising venture.”—JJ Ramberg (Host of MSNB’s Your Business)“David S. Rose has seen it all, over many years and across thousands of companies, and then, to the great benefit of the rest of us, has distilled the essence of what it takes to succeed. I can’t say strongly enough how much I feel that following the checklist David has created will help you make your company more successful.”—Bill Gross (Founder and CEO of Idealab)"When it comes to startups, David S. Rose is a legend in Silicon Alley. The Startup Checklist lives up to Rose’s reputation as a wellspring of insightful advice. It is an easy read with actionable plans, full of both inspiration and practical learnings. A must read for any technology entrepreneur. "—Andrew Weinreich ( Inventor of Social Networking (and sixdegrees, meetmoi, xtify, and...)————For some other reviews, see:Archie D’Cruz's answer to What is a review of David S. Rose's The Startup Checklist?Aspiring Startup Entrepreneur? There’s One Book You Should Read This Year - Bplans BlogThe Startup Checklist by David S. Rose | Kirkus ReviewsAmazon.com: The Startup Checklist: Customer ReviewsThe Startup Checklist: Reviews on GoodReadsStarting a Company? Don’t Hire a Cheap Lawyer

I just came across these must read list of books for physicians on Medscape, maybe of interest to you:The Emperor of all Maladies: A Biography of Cancer, by Siddhartha Mukherjee, MD, DPhilThis book was awarded the 2011 Pulitzer Prize for general nonfiction, and it has received acclaim from critics and clinicians alike. Dr. Bruce Cheson, a hematologist and professor at Georgetown University in Washington, DC, recently gave a copy of the book to each his fellows. "It talks not only about how we arrived at our current surgical techniques and chemotherapy, but also about the people and how important their personalities and their drive were; what they did; and how they sometimes missed things," he explains. "I gave this book to my fellows because my feeling is, if you don't know where you have been, you are not going to know where you are going." Dr. Cheson describes the book as well written and easy to read. "It's a valuable lesson in how to deal with patients, how to deal with the system, and the importance of the history of oncology and hematology."Cutting for Stone, by Abraham Verghese, MDSet in Ethiopia, this epic novel tells the story of twin brothers who grow up at a mission hospital and eventually become doctors themselves. It has appeared on several prestigious bestseller lists, including The New York Times, and was soundly endorsed by Medscape readers. In the book, one of the brothers recalls this advice from his surgeon father: "The key to your happiness is to own your slippers, own who you are, own how you look, own your family, own the talents you have, and own the ones you don't. If you keep saying your slippers aren't yours, then you'll die searching, you'll die bitter, always feeling you were promised more. Not only our actions, but also our omissions, become our destiny."The Immortal Life of Henrietta Lacks, by Rebecca SklootThis book has won numerous awards, including the National Academy of Sciences' 2011 Best Book Award. One Medscape reader described it as "un-put-downable." Hematologist Dr. Bruce Cheson gave a copy of this book to each of his fellows: "This is a story of the HeLa cell -- the first human cancer cell to be grown and cultured," he explains. "Not only did it grow and culture, but it kept growing and taught us lessons about how to turn genes on and off. It led to the development of the polio vaccine and other vaccines as well as all sorts of tissue culture techniques." This true story began at a time when "informed consent" had not yet been widely adopted, so the family of Henrietta Lacks -- source of the HeLa cells -- only learned the truth many years later. The book raises significant ethical issues, Dr. Cheson says. "I don't know of a book that I have read in the last few years that I can recommend as highly as this one."The House of God, by Samuel ShemOriginally published in 1978 amid considerable controversy, this book has become a cult favorite among physicians. It offers a fictional account of a medical intern at Harvard Medical School's Beth Israel Hospital and it satirizes the dehumanizing demands of residency. "I read House of God over and over as an intern and resident," says Dr. John Tydings, an orthopedic surgeon in New Jersey. "I read it again after residency and thought it was one of the saddest books I ever read," he continues. "Much is outdated but much is still painfully true." The latest book by Samuel Shem, The Spirit of the Place, has been given a much warmer reception, winning numerous awards and accolades from clinicians and book reviewers.Arrowsmith, by Sinclair LewisPublished in 1925, this book won the Pulitzer Prize the next year (though the author refused to accept it). It follows the life and evolution of Dr. Martin Arrowsmith, while providing social commentary on the state of medicine in the United States. The book has received much critical acclaim, and it is still popular among current physicians. "This book inspired me to pursue a career in medicine and research," wrote one anonymous physician in our Medscape survey; that sentiment was echoed by others.Complications: A Surgeon's Notes on an Imperfect Science, and Better, by Atul Gawande, MD, MPHOne physician responding to our online survey recommended "anything written by Atul Gawande." Many other respondents offered more specific praise for these 2 books. "Gawande's prose is elegantly simple with practical teaching points," wrote one physician. Another said he gave a copy of Better to every resident in the program after finishing it himself. Dr. Gawande practices general and endocrine surgery at Brigham and Women's Hospital in Boston. He is also a frequent columnist for The New Yorker magazine, and his columns are frequently discussed on medical blogs.The Spirit Catches You and You Fall Down, by Anne FadimanThe sub-title captures the essence of this book: A Hmong Child, Her American Doctors, and the Collision of Two Cultures. This book "really changed my approach to my culturally diverse practice," writes a Medscape endocrinologist. "Should be required reading for all future MDs," adds a Medscape family physician.Sandeep Jauhar isn't a paragon of virtue, which is what makes this warts-and-all memoir about his residency at a New York City hospital so compelling. Jauhar, now a cardiologist and director of the Heart Failure Program at Long Island Jewish Medical Center, presents himself to naked scrutiny, and his honesty has earned favorable reviews from physician-readers."Jauhar, like most of us, is neither a saint nor an apostle of medicine. He is a little sarcastic, a little bitter, a little naive, a little smarter, and a little stupider than everyone else; in short, the character he writes for himself is the perfect protagonist for a medical internship," Dr. Noah Raizman writes in his review for The Lancet. Dr. Vincent Lam expressed a similar view in the New York Times: "The story he tells here is antiheroic, full of uncertainty, doubt, and frank disgust, aimed at both himself and, sometimes, his patients.Intern succeeds as an unusually transparent portrait of an imperfect human being trying to do his best at a tough job."Oliver Sacks is a very, very busy man. Currently a professor of neurology at the NYU School of Medicine, Sacks is known for his numerous collections of case histories that explore the hinterlands of the mind. In his collections, which include the seminal The Man Who Mistook His Wife for a Hat and An Anthropologist on Mars, Sacks describes patients struggling to live with myriad neurologic conditions, including Tourette syndrome, autism, musical hallucinations, epilepsy, phantom limb syndrome, schizophrenia and Alzheimer disease.In Hallucinations, Sacks explores the root causes -- sensory deprivation, intoxication, illness, or injury -- that can produce everything from colorful blobs of light to out-of-body experiences and shares his own experiences with hallucinogenic drugs. Kirkus Reviews notes that after so many books, Sacks' approach can sound formulaic, but "it's still effective -- largely because Sacks never turns exploitive, instead sketching out each illness with compassion and thoughtful prose."Vertosick's chronicle of his neurosurgery residency demystifies brain surgery. The neurosurgeon is neither God nor masked wizard, and, as Publishers Weekly notes, brain surgery is revealed for what it truly is: "risky, messy and often frustrating." Vertosick presents cases -- a baby with a brain tumor, a paraplegic, an expectant woman who refuses treatment, a minister with a bullet in his skull -- but more important, he presents people: living, breathing people whose stories all too often don't end well.In so doing, Vertosick chronicles the changes and development of a central character: himself. When the Air Hits Your Brain documents the metamorphosis of a naive intern into an accomplished neurosurgeon.In The Creative Destruction of Medicine, Topol pulls back the curtain on the brave new frontier of mobile medical technology. He shows how mobile technologies are enabling -- or have the potential to enable -- people to capture all the relevant data necessary to develop individualized, precision therapies; avoid disastrous side effects of medication; and, ultimately, prevent many diseases.Despite the field's wondrous potential, resistance from the medical community is preventing many of these innovations from flowering, he argues. For nontechies, 320 pages on sophisticated digital technology may sound dry as toast, but Topol's prose has won notable praise. Physician-author Siddhartha Mukherjee writes, "Topol's analysis draws us to the very frontlines of medicine, and leaves us with a view of a landscape that is both foreign and daunting. He manages to recount this story in simple, lucid language -- resulting in an enthralling and important book."Sometimes life takes a left turn. Percy earned his medical degree in 1941, but his career was sideswiped when he contracted tuberculosis while performing an autopsy as an intern. While recuperating, Percy turned his hand to writing. He never went back to medicine, opting instead to study "the pathology of the soul" rather than that of the body. That choice has made the literary world a richer place. A modern classic about a young man's alienation, The Moviegoer won the National Book Award in 1961.On the surface, Atul Gawande's latest book appears to be an ode to the most mundane quality-control tool imaginable: the checklist. But Gawande, whose previous book, Complications: A Surgeon's Notes on an Imperfect Science, was a finalist for the 2002 National Book Award, isn't one to linger on the surface. Manifesto is an insightful commentary on the spiraling complexity of modern medicine and a thoughtful response for dealing with it.As best-selling author Malcolm Gladwell notes in his Amazon review, "It has been years since I read a book so powerful and so thought-provoking." The New York Times was equally enthusiastic, noting, "In an age of unremitting technological complexity, where the most basic steps are too easy to overlook and where overlooking even one step can have irremediable consequences, something as primitive as writing down a to-do list to 'get the stupid stuff right' can make a profound difference." High praise for the humble checklist.More Books Recommended byMedscape Readers and ExpertsCybermedicine: How Computing Empowers Doctors and Patients for Better Health Care, by Warner V. SlackOutliers: The Story of Success, by Malcolm GladwellMy Stroke of Insight: A Brain Scientist's Personal Journey, by Jill Bolte Taylor, PhDThe Social Transformation of American Medicine, by Paul Starr, PhDNot as a Stranger, by Morton ThompsonThe Diving Bell and the Butterfly, by Jean-Dominique BaubyMovies:Not as a StrangerOlivia de Havilland, Robert Mitchum, Frank SinatraDirector: Stanley Kramer, 1955Life was always tough for medical residents. A poor but striving medical student, Lucas Marsh (Mitchum), marries an older woman, Kristina Hedvigson (de Havilland), knowing she can pay for his education. The film follows Luke as he seeks perfection in his work, complicates his personal life, and eventually receives a devastating and painful lesson in his own fallibility. Along the way, he has an affair with a wealthy woman (Gloria Grahame), while his best friend since medical school, Alfred Boone (Sinatra), intercedes to try to keep Luke's marriage intact. Charles Bickford portrays the strong but compassionate physician who plays a significant role in his life. Notably, open heart surgery is shown, with an actual human heart depicted in the close-ups.Virginia Bruce, Robert MontgomeryYellow JackRobert Montgomery, Virginia Bruce, Lewis StoneDirector: George B. Seitz, 1938The early importance of controlled clinical trials gets scrutiny in this emotional movie from the 1930s. Set in Havana at the end of the Spanish-American War, the film depicts Major Walter Reed (Lewis Stone), a surgeon with the US Army Medical Corps, as he and his staff struggle to combat "yellow jack" -- yellow fever, which is killing thousands of Cubans and American soldiers. Reed learns that a retired Cuban physician, Carlos Finlay (Charles Coburn), had proposed nearly 20 years earlier that the Stegomyia mosquito was the carrier of the disease. But his theory had been roundly dismissed, and Reed, understanding that he could not prove it without testing it on humans, begins to arrange to test 2 groups of men under controlled conditions. The drama surrounding the men who volunteer to be exposed to the disease is riveting, as they know there is no cure.Ronald Colman, Helen HayesArrowsmithRonald Colman, Helen HayesDirector: John Ford, 1931This film ultimately poses the question, "How far will you go to do what you believe is right?" Arrowsmith (Colman), fresh out of medical school and wishing to be a researcher, finds himself instead as a country doctor in his wife's small Minnesota town, where the hardships and responsibilities of the young physician are nicely delineated. He subsequently develops a serum (on his kitchen table) that saves dying cattle, which allows him to assume the coveted work of a researcher. He travels to the West Indies to test a new serum against bubonic plague. However, setbacks and rampant disease take a toll on his wife, his marriage, and ultimately on his approach to his research. The film was adapted from the Pulitzer Prize-winning novel by Sinclair Lewis.From left: Laurence Fishburne, Kate WinsletContagionMatt Damon, Kate Winslet, and Jude LawDirector: Steven Soderbergh, 2011In this medical thriller, researchers and public health officials race to identify and contain a deadly airborne virus transmitted by fomites and to develop a vaccine to combat it. The film, with a star-studded cast that includes Matt Damon, Marion Cotillard, Laurence Fishburne, and Jude Law, explores the impact of a pandemic on the social order. The screenwriter, Scott Z. Burns, consulted with World Health Organization representatives and prominent medical experts, and scientists generally vouched for the accuracy of the results. Contagion, says Dr. Auwaerter, is "a great infectious diseases film that does a more than credible job on a scientific basis, while keeping you entertained, all the while exploring how we react in crises, from medical choices to medicinal hucksterism."

First, let me qualify my answer:The stocks below are Research Leads. I am NOT saying they are great investments; I am saying they are worth your research time and efforts. Due diligence might identify problems that will change their perceived value.These companies should be considered for long-term (5+ years) investments. All current problems for these companies and their industries must be viewed from this perspective. The leads might be worthless for people with shorter-term investment horizon.With that in mind, I am willing to spend time to understand the prospects of the following businesses because they appear historically undervalued. If their future operations return to normal or at least don't deteriorate, they might be great long-term investments.INTC (Intel). Semiconductor manufacturer. ROE 25%, dividend yield 4.2%, virtually no debt, healthy cash position and free cash flow, buying back shares. It was similarly cheap only 3 times in the past 15 years.GLW (Corning). Materials company. ROE 10%, dividend yield 2.5%, low debt, very strong cash position, buying back shares. It has never been so cheap in the past 10 years. I think market overestimates its current headwinds and underestimates its ability to innovate in the long run. (Disclosure: I am long GLW).EXC (Excelon). Nuclear utility. ROE 5% (historical 20%), dividend yield 7%. Cheapest valuation in 15 years. Excelon is affected by the recently made large acquisition and unusually low natural gas prices. However, all these concerns have been sufficiently priced-in, and at this valuation level it's worth digging.JEC (Jacobs Engineering). Construction company. ROE 12%, no dividend. Almost no debt, strong cash position. Valuation has been so cheap only 2 times within the past 15 years. Interesting business model, unusual for its industry.WAG (Walgreen). Drug store chain. ROE 12%, dividend yield 3.3%, no debt, strong cash position, share buy-back. Valuation is second cheapest within past 15 years. Anything below $30/share seems interesting.APA (Apache), HES (Hess Corp). Two energy companies. 10-12% ROE, small debt, strong balance sheets. Affected by unusually low natural gas prices. Valuation is the cheapest in the past 15 year, certainly worth researching.Somewhat more challenging cases with higher long-term risks:WDC (Western Digital). Data storage devices. Great economics (20% ROE), clean balance sheet, strong cash flow, cheapest valuation in the past 10 years. Industry is going through a technological change (solid state drives, etc), need to understand in depth how company plans to handle the change. If it manages to adapt, potentially great investment.DV (Devry). Education Services. Strong company with good balance sheet, buying shares back, cheapest valuation in its history. Industry is going through a regulatory change that might have strong affect on its business model. My view is that the current negative publicity storm is blown out of proportion and well priced-in. If the industry adapts, will be a great investment.For those who want to learn how to research this type of leads:The Five Rules for Successful Stock Investing: Pat Dorsey One of the best books to understand long-term investing conceptuallyThe Investment Checklist: The Art of In-Depth Research: Michael ShearnPractical and useful book on deep fundamental research